[Research progress of thrombolytic therapy for high risk and intermediate-high risk pulmonary thromboembolism].

Yang, J J; Zhang, Y; Zhai, Z G; Yang, Y H

Yang, J J; Zhang, Y; Zhai, Z G; Yang, Y H.

Afiliação

Yang JJ; Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Institute of Respiratory Medicine, Beijing 100020, China.
Zhang Y; Peking University China-Japan Friendship School of Clinical Medicine, Department of Pulmonary and Critical Care Medicine,National Respiratory Disease Center,China-Japan Friendship Hospital,Beijing 100029,China.
Zhai ZG; Peking University China-Japan Friendship School of Clinical Medicine, Department of Pulmonary and Critical Care Medicine,National Respiratory Disease Center,China-Japan Friendship Hospital,Beijing 100029,China.
Yang YH; Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Institute of Respiratory Medicine, Beijing 100020, China.

Zhonghua Jie He He Hu Xi Za Zhi ; 46(7): 720-725, 2023 Jul 12.

Article em Zh | MEDLINE | ID: mdl-37402665

Assuntos

Embolia Pulmonar; Terapia Trombolítica; Humanos; Embolia Pulmonar/tratamento farmacológico; Embolia Pulmonar/etiologia; Fibrinolíticos/uso terapêutico; Hemorragia/induzido quimicamente; Hemorragia/tratamento farmacológico; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Terapia Trombolítica Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Jie He He Hu Xi Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google